Medlife, India’s e-Health platform, today announced that it has partnered with National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited labs to provide users with the option of testing for Covid-19, at home, as per the Medlife’s official release.
The company stated that in accordance with Government guidelines, users must display Covid-19 symptoms and have a prescription from a registered physician to avail Covid-19 testing at home. Users meeting these conditions and seeking to get tested can do so by raising a call-back request through Medlife. The price of the test is set at INR 4,500 and is conducted by labs authorized by ICMR to perform Covid-19 testing using Real-Time PCR methodology.
Medlife mentioned that samples will be collected by Medlife’s partner labs, who will send phlebotomists in Personal Protective Equipment Kit, to ensure the safety of all persons involved.
Reports from the Covid-19 tests, which require a simple nose or throat swab sample, would be available within 24 to 48 hours from the set appointment time, Medlife claimed.
The Covid-19 testing service is currently available in Mumbai, Delhi, Noida, Ghaziabad, and Faridabad, with Gurgaon and Pune to be added shortly.
Medlife also announces the launch of its e-consultation services and has impaneled 1,500 doctors across India for the same. E-consultation services will be provided in areas, including Diabetology, Cardiology, Oncology, Neurology, Gynaecology, Paediatrics, Orthopaedic, Pulmonology, Dermatology, GP, and ENT.
E-consultation fee ranges from Rs 199 to Rs 599 and is currently available on Medlife’s Android app. The e-consultation services are currently enabled through a call, with video and chat features to be added soon.
Ananth Narayanan, Co-founder and CEO Medlife stated in the official release: “We are partnering with ICMR-authorised labs to aid in the rapid scaling up of Covid-19 testing in India, an essential measure to check the spread of the virus in the country. As we play our part in the nation’s fight against the pandemic, we are determined to ensure that regular and chronic patients continue to receive quality healthcare services.”
He further added: “The launch of our e-consultation service is aimed at encouraging vulnerable and at-risk patients, especially ones with chronic diseases, to direct their concerns to our highly-trained doctors from the safety and comfort of their homes.”